A new class of hemophilia drugs.

[Cazandra Campos-MacDonald]

Hi Milos, May I ask which drug you are referring to? Are you talking about the recent news regarding gene therapy?

[Milos]

Activated protein C inhibitor for correction of thrombin generation in hemophilia A blood and plasma.

[Cazandra Campos-MacDonald]

Milos, I’m doing some research and will get back to you soon 🙂

[Cazandra Campos-MacDonald]

Hi Milos,
I have reached out to a few clinicians about your question, and they have no information to share. I will keep my ears open and ask that you do the same.

Thank you!! Have a great week, Milos 🙂

[Milos]

Thank you, Cazandra.

[PaulC]

Milos, there is no anti-activated protein C (anti-APC) drug on the on the market in any country. ApcinteX Ltd and Centessa Pharmaceuticals are testing (phase 1/2 clinical trial) an anti-APC drug called SerpinPC (clinical trial # NCT04073498), with results expected in October 2023. See press release here: https://investors.centessa.com/news-releases/news-release-details/centessa-pharmaceuticals-announces-positive-topline-data-proof